I am...
I am...
The number of grants awarded by the Histiocytosis Association varies each year. It is determined by a variety of factors including, but not limited to, the quality of eligible applications received and the availability of funds.
Use the filters below to see information for all of the research projects the Association has funded since 1992.
To filter by year and disease type, select the year first.
- All
- ECD
- HLH/FEL/FHL
- JXG
- LCH
- Rare Histiocytic Disorders and Other Topics
- RDD
Mechanism of Interferon Gamma Induced Liver Sinusoidal Endothelial Cell Disruption in Familial Hemophagocytic Lymphohistiocytosis Hepatitis
Principal Investigator: Tamir Diamond Children’s Hospital of Philadelphia, Philadelphia, PA USA Date of Award: December 2025 Amount…
Evaluation of the Bromodomain and Extra Terminal (BET) Domain Activity as an actionable Target in Hemophagocytic Lymphohistiocytosis (HLH)
Principal Investigator: Polina Shindiapina The Ohio State University, Ohio, USA Date of Award: December 2025 Amount of Award:…
Deciphering neurodegeneration in LCH
Principal Investigator: Raphaela Schwentner St. Anna Children’s Cancer Research Institute, Vienna, Austria Date of Award: December 2025…
Mapping the Spatial Heterogeneity and Ontogeny of Pathogenic Dendritic Cells in Langerhans Cell Histiocytosis
Principal Investigator: Florent Ginhoux Gustave Roussy, Villejuif, France Date of Award: December 2025 Amount of Award: 50,000…
Exploring Macrophage Differentiation In The Context Of Xanthogranuloma
Principal Investigator: Astrid van Halteren Erasmus University Medical Center Rotterdam, Rotterdam, Netherlands Date of Award: December 2024…
Validation and Implementation of a Novel Tool for Predicting Pathogenicity of Variants of Uncertain Significance in Familial Hemophagocytic Lymphohistiocytosis Genes
Principal Investigator: Kim Nichols St. Jude Children’s Hospital, Memphis,Tennesse,USA Date of Award: December 2024 Amount of Award:…
Single cell genomic analysis of the clonal architecture of histiocytic neoplasms
Principal Investigator: Paul Milne Haematopoesis and Immunity Lab, Newcastle University, Newcastle upon Tyne,UK Date of Award: December…
Spatial understanding of Erdheim-Chester Disease and associated neurodegeneration for future precision medicine
Principal Investigator: Egle Kvedaraite Karolinska lnstitutet and Karolinska University Hospital, Stockholm, Sweden Date of Award: December 2024…
Prime editing-based correction of UNC13D
Principal Investigator: Dr. Toni Cathomen Medical Center – University of Freiburg Breisgau, Germany Date of Award: December…